Follow the 셀트리온제약 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 셀트리온제약 has recorded 97 reports. Market capitalisation: €1,898.7bn. The latest transaction was reported on 10 April 2026 (Purchase). Among the most active insiders: 셀트리온. All data is openly available.
97
Insider Decl.
0
Thresholds
€16m
17 ops.
Buy Volume
·
1 ops.
Sell Volume
30Σ signal
Buys €16m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 15,395 of 26,220 companies
46.6
score / 100
Value
40
Quality
53
FCF yld3.7%
Earn yld2.1%
EV/EBITDA25.5x
ROE8.9%
Gross mgn31%
Net mgn7.2%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
